Receptors reduced in Sm, COPD-S and COPD-ES but limited to either NTHI (complement receptor CD11b), or SP (lipid antigen receptor CD1d and TLR4) may also reflect early and sustained alterations in immunity specific to individual bacteria or class associated with CAP. Here, TLR4 is linked to chronic obstructive pulmonary disease.